Docusate Sodium Oral Liquid 81033-0022-50
- Manufacturer
- Kesin Pharma Corporation
- Dosage Form
- Liquid
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- April 1, 2025
- Listing Expires
- December 31, 2026
- Application
- M007
Active Ingredients
| Ingredient | Strength |
|---|---|
| Docusate Sodium | 100 mg/10mL |
Selected Package
81033-0022-50Selected100 CUP, UNIT-DOSE in 1 CASE (81033-022-50) / 10 mL in 1 CUP, UNIT-DOSE (81033-022-10)